February 19, 2021 Experience Fantasia $150 million high-yield notes reopening and concurrent tender offer We advised the initial purchasers on the offering and the dealer managers on the tender offer for Fantasia’s senior notes
February 19, 2021 Experience InnoCare Pharma HK$3.04 billion share placement We advised InnoCare Pharma in the placement of new shares
February 18, 2021 Experience New Horizon Health HK$2.04 billion IPO We advised New Horizon Health on its IPO and HKEX listing
February 17, 2021 Experience Akeso HK$1.19 billion share placement We advised the placing agent in the placement of new shares
February 17, 2021 Experience UP Fintech $65 million convertible notes private placement We are advising UP Fintech, a Nasdaq-listed online brokerage firm, on its private placement of convertible notes
February 17, 2021 Experience Youdao $238 million equity follow-on offering We advised Youdao on its offering of ADSs
February 11, 2021 Experience Adagene $161 million IPO We advised Adagene on its IPO and Nasdaq listing
February 9, 2021 Experience Janus Henderson Group $891.7 million secondary offering We advised the underwriter on the equity offering
February 5, 2021 Experience China SCE $350 million high-yield notes offering We advised the initial purchasers on the Regulation S senior notes offering
February 5, 2021 Experience Hopson Development $100 million high-yield notes reopening We advised the initial purchasers on the Regulation S senior notes offering